153 related articles for article (PubMed ID: 8951605)
1. Organ-specific circulating heart autoantibodies in Chagas' cardiomyopathy: exploratory study.
Nava A; González-Ortega ME; Monteón V; Reyes PA
J Clin Lab Anal; 1996; 10(6):380-3. PubMed ID: 8951605
[TBL] [Abstract][Full Text] [Related]
2. Presence of antiheart and antiskeletal muscle glycolipid autoantibodies in the sera of patients with chagasic cardiopathy.
Laguens RP; Argel MI; Chambó J; Storino R; Cabeza Meckert PM
Can J Cardiol; 1994 Sep; 10(7):769-76. PubMed ID: 7922834
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
[TBL] [Abstract][Full Text] [Related]
4. Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice.
Tibbetts RS; McCormick TS; Rowland EC; Miller SD; Engman DM
J Immunol; 1994 Feb; 152(3):1493-9. PubMed ID: 8301148
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.
Levin MJ; Hoebeke J
Autoimmunity; 2008 Sep; 41(6):429-33. PubMed ID: 18781468
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients.
Wallukat G; Muñoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Duchen D; Diaz Ramirez I; Borges AC; Schimke I
J Am Coll Cardiol; 2010 Feb; 55(5):463-8. PubMed ID: 20117461
[TBL] [Abstract][Full Text] [Related]
7. [Determination of EVI antibodies in chronic Chagas' cardiopathy].
Vieira LM; Vieira AR; Albanesi Filho FM; Cruz P di M; da Cunha GB; Sarno EN
Arq Bras Cardiol; 1985 Dec; 45(6):413-6. PubMed ID: 3915861
[No Abstract] [Full Text] [Related]
8. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to human heart conduction system in Chagas' disease.
Arce-Fonseca M; Ballinas-Verdugo MA; Reyes PA; Aranda-Fraustro A; Monteón VM
Vector Borne Zoonotic Dis; 2005; 5(3):233-6. PubMed ID: 16187891
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune response against myocardial tissue in Chagas' disease.
Cossio PM; Casanova MB; Bellido C; Arce L; Storino R; de la Vega MT; Diez C; Arana RM
Medicina (B Aires); 1985; 45(6):643-8. PubMed ID: 3916122
[No Abstract] [Full Text] [Related]
11. Organ-specific IgM autoantibodies to liver, heart and brain in man: generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis.
Daar AS; Fabre JW
Clin Exp Immunol; 1981 Jul; 45(1):37-47. PubMed ID: 7030539
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an autoimmune type antibody in the sera of patients with Chagas' disease.
Hübsch RM; Sulzer AJ; Kagan IG
J Parasitol; 1976 Aug; 62(4):523-7. PubMed ID: 822145
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of circulating autoantibodies in healthy individuals].
Teubner A; Tillmann HL; Schuppan D; Gericke G; Manns MP; Stölzel U
Med Klin (Munich); 2002 Nov; 97(11):645-9. PubMed ID: 12434272
[TBL] [Abstract][Full Text] [Related]
14. Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis.
Kato T; Miyakawa H; Ishibashi M
J Autoimmun; 2004 May; 22(3):211-6. PubMed ID: 15041041
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
16. Anti-heart autoantibodies are more frequently present in Chagas disease patients with dilated cardiomyopathy.
Nava A; Reyes PA; Monteón V; Raymond Y
Am J Cardiol; 1997 Dec; 80(12):1646-7. PubMed ID: 9416965
[No Abstract] [Full Text] [Related]
17. Long-term treatment of chronic chagasic cardioneuropathy with a mixture of gangliosides: effect on evolution of circulating antiGM1 antibodies.
Mitelman J; Gimenez L; Aparicio NJ; Cortelezzi M
J Cardiol; 1999 Oct; 34(4):189-97. PubMed ID: 10553535
[TBL] [Abstract][Full Text] [Related]
18. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome.
Morgun A; Shulzhenko N; Unterkircher CS; Diniz RV; Pereira AB; Silva MS; Nishida SK; Almeida DR; Carvalho AC; Franco M; Souza MM; Gerbase-DeLima M
J Heart Lung Transplant; 2004 Feb; 23(2):204-9. PubMed ID: 14761768
[TBL] [Abstract][Full Text] [Related]
19. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients.
Hernández-Becerril N; Nava A; Reyes PA; Monteón VM
Arch Cardiol Mex; 2001; 71(3):199-205. PubMed ID: 11665655
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
